drugset / Trial / NCT01250730
A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066
Parallel-groupOpen-label
Summary
The purpose of this study is to investigate the pharmacokinetics of single doses of PF-02341066 (150, 250, and 400 mg) in the fasted condition in Japanese healthy male volunteers.
Timeline
- Start
- 2010-12
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crizotinib | Small molecule | 150 mg | — |
| Subject | Crizotinib | Small molecule | 250 mg | — |
| Subject | Crizotinib | Small molecule | 400 mg | — |
Indications
No indication recorded.